WallStreetZenWallStreetZen

NASDAQ: GLTO
Galecto Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for GLTO

Based on 1 analyst offering 12 month price targets for Galecto Inc

Min Forecast
$36.00+20%
Avg Forecast
$36.00+20%
Max Forecast
$36.00+20%

Should I buy or sell GLTO stock?

Based on 1 analyst offering ratings for Galecto Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although GLTO's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates GLTO as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their GLTO stock forecasts and price targets.

GLTO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-08Find Out Why

1 of 1

Forecast return on equity

Is GLTO forecast to generate an efficient return?

Company
-38.21%
Industry
74.28%
Market
339.58%
GLTO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GLTO forecast to generate an efficient return on assets?

Company
-28.5%
Industry
23.71%
GLTO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GLTO earnings per share forecast

What is GLTO's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$1.06
Avg 2 year Forecast
-$1.59
Avg 3 year Forecast
-$2.31

GLTO revenue forecast

What is GLTO's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$0.0

GLTO vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GLTO$30.00$36.00+20.00%Strong Buy
JUNS$1.15N/AN/A
TAOX$5.54N/AN/A
TVRD$4.20$47.50+1,030.95%Strong Buy
CVM$5.90N/AN/A
View Top Biotech Stocks

Galecto Stock Forecast FAQ

Is Galecto Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: GLTO) stock is to Strong Buy GLTO stock.

Out of 1 analyst, 1 (100%) are recommending GLTO as a Strong Buy, 0 (0%) are recommending GLTO as a Buy, 0 (0%) are recommending GLTO as a Hold, 0 (0%) are recommending GLTO as a Sell, and 0 (0%) are recommending GLTO as a Strong Sell.

If you're new to stock investing, here's how to buy Galecto stock.

What is GLTO's earnings growth forecast for 2025-2027?

(NASDAQ: GLTO) Galecto's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 70.94%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 104.63%.

Galecto's earnings in 2025 is -$15,844,000.On average, 3 Wall Street analysts forecast GLTO's earnings for 2025 to be -$1,407,906, with the lowest GLTO earnings forecast at -$1,352,694, and the highest GLTO earnings forecast at -$1,449,316. On average, 3 Wall Street analysts forecast GLTO's earnings for 2026 to be -$2,111,860, with the lowest GLTO earnings forecast at -$2,029,042, and the highest GLTO earnings forecast at -$2,173,973.

In 2027, GLTO is forecast to generate -$3,059,489 in earnings, with the lowest earnings forecast at -$2,939,509 and the highest earnings forecast at -$3,149,474.

What is GLTO's revenue growth forecast for 2025-2027?

(NASDAQ: GLTO) Galecto's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 277.46%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.25%.

Galecto's revenue in 2025 is $0.On average, 3 Wall Street analysts forecast GLTO's revenue for 2025 to be $0, with the lowest GLTO revenue forecast at $0, and the highest GLTO revenue forecast at $0. On average, 3 Wall Street analysts forecast GLTO's revenue for 2026 to be $0, with the lowest GLTO revenue forecast at $0, and the highest GLTO revenue forecast at $0.

In 2027, GLTO is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is GLTO's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: GLTO) forecast ROA is -28.5%, which is lower than the forecast US Biotechnology industry average of 23.71%.

What is GLTO's Price Target?

According to 1 Wall Street analyst that have issued a 1 year GLTO price target, the average GLTO price target is $36.00, with the highest GLTO stock price forecast at $36.00 and the lowest GLTO stock price forecast at $36.00.

The Wall Street analyst predicted that Galecto's share price could reach $36.00 by Dec 8, 2026. The average Galecto stock price prediction forecasts a potential upside of 20% from the current GLTO share price of $30.00.

What is GLTO's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: GLTO) Galecto's current Earnings Per Share (EPS) is -$12.11. On average, analysts forecast that GLTO's EPS will be -$1.06 for 2025, with the lowest EPS forecast at -$1.02, and the highest EPS forecast at -$1.09. On average, analysts forecast that GLTO's EPS will be -$1.59 for 2026, with the lowest EPS forecast at -$1.53, and the highest EPS forecast at -$1.64. In 2027, GLTO's EPS is forecast to hit -$2.31 (min: -$2.21, max: -$2.37).

What is GLTO's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: GLTO) forecast ROE is -38.21%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.